NovaBridge Biosciences
NBP · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $197,712 | $67,230 | $69,271 | $709,112 |
| - Cash | $165,404 | $53,597 | $68,263 | $79,327 |
| + Debt | $3,481 | $3,684 | $3,882 | $3,781 |
| Enterprise Value | $35,789 | $17,317 | $4,890 | $633,566 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,114 | -$5,266 | -$12,098 | -$6,422 |
| % Margin | – | – | – | – |
| Net Income | -$5,504 | -$3,150 | -$9,062 | -$20,491 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.069 | -0.28 | -0.11 | -0.25 |
| % Growth | 75.4% | -154.5% | 56% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |